This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:protocol:olmesartan:kidney_disease [10.12.2018] – [Animal studies] sallieq | home:protocol:olmesartan:kidney_disease [02.10.2019] – [Notes and comments] sallieq | ||
---|---|---|---|
Line 55: | Line 55: | ||
MP patients with kidney inflammation and their healthcare practitioners should be extremely comforted by the fact that the patient is taking olmesartan. This is due to the great number of studies, which have found that olmesartan and other ARBs protect the kidneys from the effects of inflammation and cytokine damage. | MP patients with kidney inflammation and their healthcare practitioners should be extremely comforted by the fact that the patient is taking olmesartan. This is due to the great number of studies, which have found that olmesartan and other ARBs protect the kidneys from the effects of inflammation and cytokine damage. | ||
- | The benefits of olmesartan on patients with kidney inflammation include: | + | The benefits of olmesartan on patients with kidney inflammation include |
* decreased insulin resistance, fewer symptoms of the metabolic syndrome, and decreased inflammation in patients with chronic kidney disease.(({{pubmed> | * decreased insulin resistance, fewer symptoms of the metabolic syndrome, and decreased inflammation in patients with chronic kidney disease.(({{pubmed> | ||
Line 84: | Line 84: | ||
Olmesartan also has [[home: | Olmesartan also has [[home: | ||
- | {{tag> | + | {{tag> |
==== Animal studies ==== | ==== Animal studies ==== | ||
Line 93: | Line 93: | ||
Ability of Olmesartan to ameliorate renal injury and fibrosis in rats when taken at ultrahigh doses.(({{pubmed> | Ability of Olmesartan to ameliorate renal injury and fibrosis in rats when taken at ultrahigh doses.(({{pubmed> | ||
- | {{tag> | + | {{tag> |
===== Notes and comments ===== | ===== Notes and comments ===== | ||
- | --- //Sallie Q 02.03.2017// added section Further Reading & moved research on rats to that section | + | Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate < |
* Legacy content | * Legacy content |